As of 2025-09-18, the Relative Valuation of Ose Immunotherapeutics SA (OSE.PA) is 21.10 EUR. This relative valuation is based on P/E multiples. With the latest stock price at 5.58 EUR, the upside of Ose Immunotherapeutics SA based on Relative Valuation is 277.7%.
The range of the Relative Valuation is 13.31 - 41.87 EUR.
| Range | Selected | |
| Trailing P/E multiples | 13.9x - 25.6x | 16.5x |
| Forward P/E multiples | 12.1x - 18.5x | 13.8x |
| Fair Price | 13.31 - 41.87 | 21.10 |
| Upside | 138.2% - 649.8% | 277.7% |
| Date | P/E |
| 2025-09-17 | 3.42 |
| 2025-09-16 | 3.60 |
| 2025-09-15 | 3.64 |
| 2025-09-12 | 3.62 |
| 2025-09-11 | 3.69 |
| 2025-09-10 | 3.75 |
| 2025-09-09 | 3.75 |
| 2025-09-08 | 3.61 |
| 2025-09-05 | 3.60 |
| 2025-09-04 | 3.69 |
| 2025-09-03 | 3.71 |
| 2025-09-02 | 3.78 |
| 2025-09-01 | 3.77 |
| 2025-08-29 | 3.75 |
| 2025-08-28 | 3.77 |
| 2025-08-27 | 3.74 |
| 2025-08-26 | 3.74 |
| 2025-08-25 | 3.76 |
| 2025-08-22 | 3.87 |
| 2025-08-21 | 3.89 |
| 2025-08-20 | 3.95 |
| 2025-08-19 | 4.09 |
| 2025-08-18 | 4.22 |
| 2025-08-15 | 4.06 |
| 2025-08-14 | 3.98 |
| 2025-08-13 | 3.92 |
| 2025-08-12 | 3.81 |
| 2025-08-11 | 3.66 |
| 2025-08-08 | 3.71 |
| 2025-08-07 | 3.65 |
| 2025-08-06 | 3.70 |
| 2025-08-05 | 3.70 |
| 2025-08-04 | 3.85 |
| 2025-08-01 | 3.84 |
| 2025-07-31 | 3.92 |
| 2025-07-30 | 3.98 |
| 2025-07-29 | 4.13 |
| 2025-07-28 | 3.87 |
| 2025-07-25 | 3.84 |
| 2025-07-24 | 3.56 |
| 2025-07-23 | 3.44 |
| 2025-07-22 | 3.12 |
| 2025-07-21 | 3.16 |
| 2025-07-18 | 3.26 |
| 2025-07-17 | 3.22 |
| 2025-07-16 | 3.18 |
| 2025-07-15 | 3.12 |
| 2025-07-14 | 3.13 |
| 2025-07-11 | 3.10 |
| 2025-07-10 | 3.11 |